A $28 million settlement resolved third-party-payor claims that Vyera and Phoenixus monopolized the toxoplasmosis drug Daraprim and spiked its price. The claim deadline has passed.
Free settlement alerts
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.